Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MycoWorks

Explore full profile

A biotech company that delivers commercially viable, non-plastic and non-animal materials to the market

Emeryville, United StatesFounded 2013Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2022
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for MycoWorks and the history behind them.

About MycoWorks

MycoWorks is a cutting-edge startup that operates in the sustainable materials market, specifically focusing on the production of a leather alternative called Reishi™. This innovative material is derived from mycelium, a component of fungus, and is being hailed as a game-changer in the fashion industry due to its sustainability and performance attributes.

Read full description

The company's business model revolves around the production and sale of Reishi™ to fashion brands and designers looking for eco-friendly alternatives to traditional leather. Their products have already been incorporated into luxury items such as the Poppies Octagon Clutch by Blumera and hats by Nick Fouquet.

MycoWorks has recently celebrated its ten-year anniversary and has shown significant growth and potential. The company has opened a 136,000 square foot facility in South Carolina, the world's first commercial-scale Fine Mycelium™ plant, to scale up the production of Reishi™. This expansion indicates the company's commitment to meeting the growing demand for sustainable materials in the fashion industry.

The company operates in a lucrative market, with the leather goods market valued at over $400 billion in 2021 and projected to surpass $720 billion by 2030. If MycoWorks continues to scale up, it has the potential to capture a significant share of this market with its unique and sustainable product.

In summary, MycoWorks is a promising startup that is revolutionizing the fashion industry with its sustainable leather alternative, Reishi™. The company's recent expansion and the growing demand for eco-friendly materials suggest a bright future for this innovative firm.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2013
Headquarters
Emeryville, United States
Employees
129
Open positions
None listed
Dealroom signal
63.4/100
Industry
Health, Fashion
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biomaterials, Synthetic Biology, Sustainable Development Goals, Mycelium Technology, Industrial Technology, Advanced Materials, Climate Tech, Circular Economy, Woman Founder
Business model
Manufacturing

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
BUYOUTOther financing Feb 2026 $0 — DFX Corporation ↗
LATE VCOther financing Oct 2022 $0 — GM Ventures ↗
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

MycoWorks website traffic

Latest recorded traffic for MycoWorks is 18K monthly website visits, down 28% over the last three months. MycoWorks's team declined 28.3% over the past year.

Latest monthly visits18K 3-month web change-28% 1-year team growth-28.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A10 investors entered at this stage

  • DCVC
  • AgFunder
  • Novo Holdings
  • Wireframe Ventures
  • Cthulhu Ventures
  • Future Tech Labs
  • Susa Ventures
  • 8VC
  • John Legend
  • Natalie Portman

Series B and later6 investors entered at this stage

  • Prime Movers Lab
  • SK Networks
  • Mirabaud Asset Management
  • Decarbonization Partners
  • GM Ventures
  • DFX Corporation
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇺🇸 United States87.3%
🇫🇷 France5.1%
🇪🇸 Spain3.8%
🇳🇱 Netherlands1.3%
🇵🇰 Pakistan1.3%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MycoWorks on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MycoWorks’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.